Found 79 matching trials
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) PHASE3 To evaluate the immune response and the safety of a primary series schedule...
Show More Location
Multiple Locations
Learn More & Join Trial
Rotavirus Vaccine Produced by Butantan Institute PHASE1 The purpose of this study is to describe the safety, tolerability and immun...
Show More Location
Instituto da Criança do Hospital das Clinicas da Faculade de Medicina da USP
Learn More & Join Trial
Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021) PHASE3 To observe the safety, tolerability and immunogenicity of the administratio...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis PHASE1 The purpose of this study is to evaluate the safety of the Leish-111f + MPL...
Show More Location
Clínica de Leishmaniasis, Hospital Nacional Sur Este EsSalud
Learn More & Join Trial
Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine PHASE3 Infants aged 9 months will be randomized to receive a meningococcal vaccine...
Show More Location
Centre pour le Developpement des Vaccins du Mali
Learn More & Join Trial
A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants PHASE3 This is a Phase 3 multicentre, randomized, double blind, placebo-controlled...
Show More Location
Dr Dinesh Kumar Government Medical College, Jammu Department of Community Medicine, Government Medical College
Learn More & Join Trial
A Phase IV Study to Assess the Safety of EupentaTM Inj PHASE4 A prospective, open-label, interventional phase IV study to assess the safe...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand PHASE3 Primary Objective:
To demonstrate the non-inferiority of the SHAN6™ vaccin...
Show More Location
Investigational Site Number 7640003
Treatments Being Tested
DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus) DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b) Inactivated Poliomyelitis Vaccine Poliomyelitis Vaccine bivalent types 1 and 3 Human Rotavirus, live attenuated Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) Learn More & Join Trial
Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060) PHASE4 The study will evaluate the immunogenicity of the Diphtheria, Tetanus, Pert...
Show More Location
Multiple Locations
Learn More & Join Trial